天美传媒

Abstract

Interstitial Lung Disease (ILD) encompasses a broad spectrum of disorders characterized by inflammation and fibrosis of the lung interstitium, leading to progressive lung damage and impaired respiratory function. Recent advancements in ILD research have significantly enhanced our understanding of its pathogenesis, diagnostic methods, and treatment strategies. This review explores the latest developments in ILD, focusing on the underlying mechanisms including genetic predispositions, inflammatory and fibrotic processes, and immune system dysregulation. Advances in diagnostic techniques, such as high-resolution computed tomography (HRCT) and the use of biomarkers, have improved the accuracy and early detection of ILD. Furthermore, treatment options have evolved with the introduction of anti-fibrotic agents and targeted therapies, which aim to slow disease progression and manage symptoms more effectively. Despite these advancements, challenges remain in differentiating between ILD subtypes and optimizing patient-specific treatments. This review provides a comprehensive overview of current research and highlights future directions for improving diagnosis, treatment, and patient outcomes in ILD.